Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Female hair loss patients more likely to have dry eye and gland issues.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Some people experienced hair loss after mesotherapy treatments for hair loss.

Androgens may block hair growth signals, targeting this could treat hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.